INTENSITY THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
INTENSITY THERAPEUTICS, INC. (INTS) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 157.63 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-11
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 157.63K shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 160.43K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 160.43K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 4.01M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 157.63K shares 10-Q · filed 2026-08-11 | |
| 2026-03-31 | 160.43K shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 160.43K shares 10-Q · filed 2026-08-11 | |
| 2025-09-30 | 4.01M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 4.04M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 2.54M shares 10-Q · filed 2025-05-13 | |
| 2024-12-31 | 103.48K shares 10-K · filed 2026-03-27 | 2.59M shares 10-K · filed 2025-03-13 |
| 2024-09-30 | 1.95M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 2.04M shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 1.94M shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 1.24M shares 10-K · filed 2025-03-13 | |
| 2022-12-31 | 1.04M shares 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |